Add to ORKGFamilial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyreti
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
A method is described for detecting carriers of a variant plasma prealbumin that is associated with ...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
To report the clinical, pathologic and molecular genetic features of a Chinese family with familial ...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
A method is described for detecting carriers of a variant plasma prealbumin that is associated with ...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
To report the clinical, pathologic and molecular genetic features of a Chinese family with familial ...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...